Prasugrel and Ticagrelor Treatment Among Patients With ACS: Is There a Need for a New Randomized Trial?
- PMID: 36423971
- DOI: 10.1016/j.jcin.2022.10.019
Prasugrel and Ticagrelor Treatment Among Patients With ACS: Is There a Need for a New Randomized Trial?
Keywords: acute coronary syndrome; antiplatelet therapy; chronic coronary syndrome; drug-eluting stent(s); prasugrel; ticagrelor.
Conflict of interest statement
Funding Support and Author Disclosures The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Comment on
-
Ticagrelor vs Prasugrel in a Contemporary Real-World Cohort Undergoing Percutaneous Coronary Intervention.JACC Cardiovasc Interv. 2022 Nov 28;15(22):2270-2280. doi: 10.1016/j.jcin.2022.09.021. JACC Cardiovasc Interv. 2022. PMID: 36423970
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources